MedPath

Comparison of Dabigatran and Enoxaparin in prophylaxy of Thromboembolic events

Phase 2
Conditions
Thromboembolic Disease.
198
180-189
Registration Number
IRCT2013082513828N2
Lead Sponsor
?Soicial Security Insurance Office/ Shariati Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Patients who are candidate for total knee replacement(TKR)in shariati hospital
Age more than 18 years
patient's content
Exclusion criteria:History of:
Bleeding disorder, Recent stroke, Major surgery,trauma,Myocardial
infarction,Uncontrolled Hypertension in recent 3 months,Liver or GI disease,GI or
GU bleeding in recent 6 months,Use of NSAIDs in recent week,active malignancy,
Thrombocytopnia,Contrast over sensitivity,Renal failure

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Deep Vein Thrombophelebitis of Legs. Timepoint: 15 days after surgery. Method of measurement: Sonodoppler of Legs' Veins.
Secondary Outcome Measures
NameTimeMethod
Bleeding. Timepoint: Every day up to 15 days and then up 3 months. Method of measurement: Physical Exam.
© Copyright 2025. All Rights Reserved by MedPath